Temozolomide temodar is an oral alkylating agent approved by the fda for use in the firstline treatment of glioblastoma multiforme as well as for recurrent anaplastic astrocytoma. Identification of the substancemixture and of the companyundertaking product name. The purpose of this study was to determine the pharmaceutical acceptability and chemical stability of temozolomide. Temozolomide accord is used first with radiotherapy and then on its own. Increased o6methylguaninedna methyltransferase mgmt activitylevels within tumor tissue is associated with temozolomide resistance. Temozolomide is a prodrug and converts spontaneously to mtic which is also the known active metabolite of dacarbazine. Temozolomide tmz is an imidazotetrazine that is converted to a compound capable of alkylating dna, thus interfering with dna replication and leading to cytotoxicity in proliferating cells. It is an alkylating agent with a broad spectrum of antitumor activity, including brain tumors in. Harmful by inhalation, in contact with skin and if swallowed. Temozolomide is a second generation imidazotetrazine anticancer chemotherapeutic that is clinically approved to treat gliobastoma multiforme, anaplastic astrocytoma, and oligodendrocytoma. Temozolomide remains in your body for several days after it is taken, so some of the drug may be present in urine, stool, sweat, or vomit. Temozolomide tmz is a prodrug of 3methyltriazen1ylimidazol4carboxamide. Material may be irritating to the mucous membranes and upper respiratory tract.
Absolute neutrophil count greater than or equal to 0. Material safety data sheet of temozolomide tmz abmole. Temozolomide supplier cas 85622931 nsc 362856 ccrg. Other companies are charging thousands of dollars to set up accounts and give you access to their msds online database. Sds of temozolomide, safety data sheets, cas 85622931. Repeated administration of temozolomide to animals produced toxicity to. Temozolomide is an orally administered chemotherapeutic drug that methylates dna in a way that prevents tumor cell proliferation. Temozolomide for recurrent high grade gliomas protocol.
Temozolomide exhibits a mean elimination halflife of 1. The majority of patients received temodal, once daily for five days, repeating every 28 days up to the high dose of 200 mgm2day. Product and company identification space synonyms softwood plywood oriented strand board osb hardboard standard, tempered, perforated, paneling lumber products engineered lumber lvl, woodijoists. Temozolomide temodar american journal of neuroradiology. For research use only, not for human or veterinary use. Temozolomide chemical degradation to 5aminoimidazole4carboxamide electrochemical study ilanna c. Us20120283304a1 formulations of temozolomide for parenteral. If you are unable to swallow temozolomide, talk to your care provider or pharmacist for possible options.
Oct 25, 2017 the material is a white to light tanlight pink powder with a molecular formula of c 6 h 6 n 6 o 2 and a molecular weight of 194. Formation of toxic gases is possible during heating or fire. The present invention relates to a parenteral formulation of temozolomide comprising an excipient selected from the group consisting of bulking agents, buffers, ph adjusting agents, with the proviso that the formulation is free of dissolution enhancing agents. In this article the complete physicochemical characteristics of temozolomide intermediate and. Temozolomide 150mgm 2 orally once a day at bedtime for 5 days cycle 1 temozolomide 200mgm 2 orally once a dayat bedtime for 5 days from cycle 2 if cycle 1 tolerated repeated every 28 days for 6 cycles. No component of this product present at levels greater than or equal to 0. Temozolomide dna alkylating agent cellagen technology.
Bioequivalence has been established only when temozolomide. Pdf on jan 1, 2017, maryam omidi and others published using of cornell measuring tool cornell musculoskeletal discomfort questionnaires for assessment of the musculoskeletal disorders. As a cytotoxic alkylating agent, temozolomide is converted at physiologic ph to the shortlived active compound, monomethyl triazeno imidazole carboxamide. Chemical storage and segregation cornell university. No component of this product present at levels greater than or. Pneumocystis pneumonia pcp prophylaxis is required during the concomitant administration of temodar and radiotherapy,and should be continued in patients. Temozolomide is rapidly and completely absorbed after oral administration. Sigmaaldrich offers a number of temozolomide products. Temozolomide tmz is an oral dna methylating, chemotherapeutic agent. Commission regulation eu no 2015830 of 28 may 2015. Other information text of r phrases mentioned in section 3 r61 may cause harm to the unborn child. Identification of the substancemixture and of the companyundertaking 1.
Temozolomide tmz nsc362856, ccrg81045 cas 85622931. The crystal structures of temozolomide polymorphs, as well as its cocrystals with 4,4bipyridinen,ndioxide have been reported by jagadeesh babu et al. Take temozolomide capsules on an empty stomach with a glass of water. It may also help to take this medicine temozolomide capsules at bedtime. Extreme high moderate low section 1 chemical product and company identification product name temozolomide statement of hazardous nature considered a hazardous substance according to osha 29 cfr 1910.
In laboratory animals, temozolomide is moderately toxic by ingestion, slightly irritating to the skin and eyes, and nonsensitizing. Temozolomide chemical degradation to 5aminoimidazole4. Temozolomide can be called as an oral alkylating agent and antitumour drug, which may show potent activity in the treatment of recurrent gliomas or glioblastoma, a kind of tumour that affects the brain or. Temozolomide, tmz brand names temodar and temodal and temcad is an oral chemotherapy drug. For some types of brain tumors, temozolomide is taken daily for 4249 days. A simplified overall mechanism of methylation of dna guanine residues at the o 6 positions by temozolomide, mismatch base pairing, and repair by an activesite cysteine residue of mgmt is shown. Taking this medicine temozolomide capsules on an empty stomach may help prevent upset stomach.
Mar 01, 2020 temozolomide is spontaneously hydrolyzed at physiologic ph to the active species, mtic and to temozolomide acid metabolite. Identification of temozolomide resistance factors in. Extend your arms to keep your balance, point your feet slightly. Mtic is further hydrolyzed to 5aminoimidazole4carboxamide aic, which is known to be an intermediate in purine and nucleic acid biosynthesis, and to methylhydrazine, which is believed to be the active alkylating species. Temozolomide has been well characterised and possesses an acceptable clinical safety profile as demonstrated in 1017 patients with malignant glioma, melanoma, or other advanced cancers. Almost all glioblastomas are intrinsically resistant to chemotherapeutic temozolomide tmz or develop resistance during treatment. Once you have started to take temozolomide, it is important to.
It is usually taken once a day in the evening at bedtime. Product and company identification space synonyms softwood plywood oriented strand board osb hardboard. Other metabolites include temozolomide acid and unidentified hydrophilic substances. The occupational safety and health administrations osha hazard communication standard 29 cfr 1910. In vivo it spontaneously degrades and reacts with water to release a methyldiazonium cation which preferentially methylates dna at n7 positions of guanine in guanine rich regions. Identification of the substancemixture and of the companyundertaking product information product name.
Jun 11, 2014 drug resistance is a major issue in the treatment of glioblastoma. Accidental release measures contain spill and collect, as appropriate. Extreme high moderate low section 1 chemical product and company identification product name temozolomide. Identification and physicochemical characteristics of. Safety data sheet temozolomide according to regulation ec no 19072006, annex ii, as amended. Safety data sheet oxytocin injection revision date 02. Temozolomide is used together with radiation therapy to treat certain types of brain tumor in adults temozolomide. These sdss are designed to provide essential information.
Temozolomide induced mammary carcinomas in both males and females at doses 0. Temozolomide dosing should be interrupted or discontinued during concomitant phase according to the hematological and nonhematological toxicity criteria as noted in table 1. Toxicity profile of temozolomide in the treatment of 300. Feb 09, 2011 temozolomide is carcinogenic in rats at doses less than the maximum recommended human dose. Repeated administration of temozolomide to animals produced toxicity to the immune system and blood e. Temozolomide is an highly orallyavailable, imidazotetrazinebased, monofunctional dna alkylating agent. Welcome to the winter safety page, where you can find all your winter safety needs. Kanzawa et al 2004 role of autophagy in temozolomide induced cytotoxicity for malignant glioma cells.
Jul 11, 2014 temozolomide has been used in the treatment of glioma and it has been shown to improve the outcomes. Dosage in cycle 1 maintenance is 150 mgm2 once daily for 5 days followed by 23 days without treatment. Temozolomide can make you more likely to get infections or may worsen any current infections. Temozolomide stability in extemporaneously compounded oral suspensions abstract temozolomide, commercially available in capsules, is an oral alkylating agent used to treat brain tumors. Stability of temozolomide in solutions aimed for oral. Material safety data sheet temozolomide sc203292 hazard alert code key. Temozolomide induces g2m arrest and apoptosis through adduction of a methyl group to o6 position of guanine in genomic dna and functional inactivation of dna repair protein o 6alkylguanine dna alkyltransferase agt in base excision. Your new online msds binder is a place for you to store the material safety data sheets you need to deploy. Safety data sheet temozolomide acid according to regulation ec no 19072006, annex ii, as amended. The main advantage of temozolomide over dacarbazine lies in its. Temozolomide is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Take temozolomide at around the same time every day. The purpose of this study was to determine the pharmaceutical acceptability and chemical stability of temozolomide in two extempora. It is an alkylating agent used as a treatment of some brain cancers. Temozolomide dosing interruption or discontinuation during concomitant radiotherapy and temozolomide. Temozolomide acid, also known as tmza, is a metabolite of temozolomide tmz with demonstrable anticancer activity in vitro. Temozolomide tmz, is an antineoplastic agent that acts through its degraded biological form. Learn to walk like a penguin to prevent winter falls. Accidental release measures contain spill and collect, as. Temozolomide vetranal, analytical standard neat form. It is an alkylating agent with a broad spectrum of antitumor activity, including brain tumors in children. Material safety data sheet material name wood and wood products. Material safety data sheet according to eec directives 91155eec and 93112ec dplubricant blue 20000201 product name.
Temozolomide is a dna methylating agent and drug resistancemodifying agent. Highlights of prescribing information pneumonia pcp pcp. Temozolomide is a triazene analog of dacarbazine with antineoplastic activity. Glioblastoma patients with decreased levels due to methylated mgmt promoter may be more likely to benefit from the combination of radiation therapy and temozolomide hegi 2008. Temozolomide is a secondgeneration alkylating agent approved by the food and drug administration in 1999 1, 2, 5. Material safety data sheet tarcevar tablets 100 mg section 1. Temozolomide induces g2m arrest and apoptosis through adduction of a methyl group to. Temozolomide stability in extemporaneously compounded oral. Supplied as 5mg, 20mg, 100mg, 140mg, 180mg and 250mg capsules pretreatment assessment. Food reduces the rate and extent of temozolomide absorption. Temodar temozolomide for injection administered via intravenous infusion. Avoid contact with people who have infections that may spread to others such as chickenpox, measles. Temozolomide should be taken whole and not crushed, cut, or dissolved. Cellagen technology llc 5940 pacific mesa court, suite 206, ca 92121, usa tel.
Other drugs may be given with this medicine temozolomide. Temozolomide stability in extemporaneously compounded. Mtic splits into monomethylhydrazine, probably the active methylating agent, and 5aminoimidazole4carboxamide aic. Certain features of will be unavailable due to maintenance from saturday morning, april 25th at 9. Temozolomide fda prescribing information, side effects and uses. The recommended dose for temozolomide as an intravenous infusion over 90 minutes is the same as the dose for the oral capsule formulation. Buy dnarna synthesis inhibitor temozolomide tmz nsc362856, ccrg81045 from abmole bioscience. Temozolomide is an alkylating agent used in the treatment of brain tumors astrocytoma and glioblastoma multiforme and melanomas, at least before the area of targeted agents and immunotherapy. Temozolomide is an alkylating agent that alkylatesmethylates guanine residues, resulting in dna damage and cell death. Newly diagnosed glioblastoma multiforme gbm concomitantly.
780 1211 789 346 140 625 635 54 1509 1370 529 692 70 140 626 646 9 804 176 1128 1231 1499 640 1259 25 99 1334 682 492 773 782